Take part in a global Parkinson’s carers survey

News

Author: Joe McAweaneyPublished: 18 July 2019

Prep: Cook: Serves:

The European Parkinson’s Disease Association (EPDA) is inviting carers from within the Parkinson’s community to take part in a survey aiming to shine a light on the physical, financial and emotional difficulties they face.

The research – supported by French healthcare devices company Air Liquide – will be used to inform future campaigns and create valuable tools to help carers and the wider Parkinson’s community.

Russell Patten, the secretary general of the EPDA, said: “Carers are such an important part of the Parkinson’s community – they provide the firm foundations that support their loved ones who are physically living with the condition.

“However, carers’ needs and quality of life are sadly, all too often, overlooked; this can lead to devastating and lasting effects on the individual and the wider society.”

The survey is open until 6 September 2019, and is available in English, French, German Italian, Danish, Dutch, Portuguese, Slovenian and Spanish.

For more information on caring and Parkinson’s please visit the EPDA website.

Listen to Episode Two of the Parkinson’s Life podcast, “Caring for a family member with Parkinson’s”, available on SoundCloud, iTunes and YouTube.

Parkinson’s may originate in the gut, says new study

Last Month

Next Month

Go Back

Share this story

Comments

Advances

Is this wearable device the future of Parkinson’s care?

How a symptom-tracking watch could improve Parkinson’s care services

Apple says new CareKit platform will ‘empower’ Parkinson’s patients

Open-source platform to transform the way we think about health

Game of Thrones star pedals for Parkinson’s

Enzo Cilenti saddles up with his dad, who has Parkinson's, for fundraising

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition. As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s. The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be…

US hospital initiative improves on-time administration of Parkinson’s medication

Late or missed doses of Parkinson’s medication in hospitals can lead to longer stays and greater morbidity. To counteract this issue, a team of healthcare professionals in the US launched a project to improve the on-time administration of levodopa to people with Parkinson’s. As part of the initiative – published in the Journal of Parkinson’s Disease – several measures were implemented, including electronic alerts for nurses, stocking automated medication dispensing machines with carbidopa-levodopa products, reporting to nurse unit managers on timeliness of medication administration and more. Dr Martha A Nance, the project’s lead investigator, said: “This project was very rewarding for our team, because of its obvious, immediate, and important impact on patient care. “We have reason to think that timely administration of carbidopa-levodopa may be associated with shorter stays and better outcomes and satisfaction. Anecdotally, patients have reported being surprised and pleased that nurses were reminding them that medication…

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Take part in a global Parkinson’s carers survey

News

Author: Joe McAweaneyPublished: 18 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

Is this wearable device the future of Parkinson’s care?

Advances

Apple says new CareKit platform will ‘empower’ Parkinson’s patients

Perspectives

Game of Thrones star pedals for Parkinson’s

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

US hospital initiative improves on-time administration of Parkinson’s medication

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

{title}

Subscribe

Take part in a global Parkinson’s carers survey

News

Author: Joe McAweaneyPublished: 18 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Advances

Is this wearable device the future of Parkinson’s care?

Advances

Apple says new CareKit platform will ‘empower’ Parkinson’s patients

Perspectives

Game of Thrones star pedals for Parkinson’s

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

US hospital initiative improves on-time administration of Parkinson’s medication

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

{title}

Subscribe

Sign in